Once-Daily Moxifloxacin Therapy for Community-Acquired Pneumonia in General Practice: Evidence from a Post-Marketing Surveillance Study of 1467 Patients

By H. Koch  

Clinical Drug Investigation, Vol. 24, Iss. 8, 2004-01 ,pp. : 441-448

Adis International

Access to resources Recommend Favorite

Safety and efficacy of olmesartan: an observational pooled-analysis of 156,682 hypertensive patients

By Scholze Jüürgen   Schaefer Angie   Kreutz Reinhold  

Expert Opinion on Drug Safety, Vol. 10, Iss. 2, 2011-03 ,pp. : 185-196

Informa Healthcare

Access to resources Recommend Favorite

Moxifloxacin Safety: An Analysis of 14 Years of Clinical Data

By Tulkens Paul M.  

Drugs in R&D, Vol. 12, Iss. 2, 2012-06 ,pp. : 71-100

Adis International

Access to resources Recommend Favorite

The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports

By Derijks Hieronymus   Meyboom Ronald   Heerdink Eibert   Koning Fred   Janknegt Rob   Lindquist Marie   Egberts Antoine  

European Journal of Clinical Pharmacology, Vol. 64, Iss. 5, 2008-05 ,pp. : 531-538

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Efficacy of Inhaled Zanamivir for the Treatment of Patients with Influenza B Virus Infection: A Pooled Analysis of Randomised, Placebo-Controlled Studies

By Osterhaus A.D.M.E.  

Clinical Drug Investigation, Vol. 20, Iss. 4, 2000-10 ,pp. : 223-228

Adis International

Access to resources Recommend Favorite